Aytu Biopharma, Inc. (AYTU)
2.30
-0.01
(-0.43%)
USD |
NASDAQ |
Feb 20, 16:00
2.33
+0.03
(+1.30%)
After-Hours: 20:00
Aytu Biopharma Total Liabilities (Quarterly) : 107.80M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Altimmune, Inc. | 32.85M |
| Actinium Pharmaceuticals, Inc. | 42.37M |
| Aldeyra Therapeutics, Inc. | 28.56M |
| Annovis Bio, Inc. | 4.033M |
| BioAtla, Inc. | 47.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 122.00M |
| Shareholders Equity (Quarterly) | 14.20M |
| Debt to Equity Ratio | 1.556 |
| Current Ratio | 1.163 |
| Net Debt Paydown Yield | -2.81% |